Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-25-016743

Director bought 168 shares at an average $5.24 ($881)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jones James Director 2025-03-03 Purchase 10b5-1 +10 $5.54 $55 42,656 D
Jones James Director 2025-03-04 Purchase 10b5-1 +10 $5.11 $51 42,666 D
Jones James Director 2025-03-05 Purchase 10b5-1 +10 $6.75 $68 42,676 D
Jones James Director 2025-03-06 Purchase 10b5-1 +10 $6.57 $66 42,686 D
Jones James Director 2025-03-07 Purchase 10b5-1 +10 $6.51 $65 42,696 D
Jones James Director 2025-03-10 Purchase 10b5-1 +7 $5.85 $41 42,703 D
Jones James Director 2025-03-11 Purchase 10b5-1 +7 $4.85 $34 42,710 D
Jones James Director 2025-03-12 Purchase 10b5-1 +7 $5.17 $36 42,717 D
Jones James Director 2025-03-13 Purchase 10b5-1 +7 $5.47 $38 42,724 D
Jones James Director 2025-03-14 Purchase 10b5-1 +7 $5.38 $38 42,731 D
Jones James Director 2025-03-17 Purchase 10b5-1 +7 $5.41 $38 42,738 D
Jones James Director 2025-03-18 Purchase 10b5-1 +7 $5.12 $36 42,745 D
Jones James Director 2025-03-19 Purchase 10b5-1 +7 $5.41 $38 42,752 D
Jones James Director 2025-03-20 Purchase 10b5-1 +7 $5.07 $35 42,759 D
Jones James Director 2025-03-21 Purchase 10b5-1 +7 $4.89 $34 42,766 D
Jones James Director 2025-03-24 Purchase 10b5-1 +8 $4.42 $35 42,774 D
Jones James Director 2025-03-25 Purchase 10b5-1 +8 $4.45 $36 42,782 D
Jones James Director 2025-03-26 Purchase 10b5-1 +8 $4.41 $35 42,790 D
Jones James Director 2025-03-27 Purchase 10b5-1 +8 $4.20 $34 42,798 D
Jones James Director 2025-03-28 Purchase 10b5-1 +8 $4.20 $34 42,806 D
Jones James Director 2025-03-31 Purchase 10b5-1 +8 $4.29 $34 42,814 D
Open-market purchases · 168 sh · avg $5.24 · $881
Loading xslF345X05/wk-form4_1743788254.xml…